Cargando…

Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness

BACKGROUND: Subxiphoid uniportal video‐assisted thoracoscopic surgery (SVATS) is more technically challenging than intercostal uniportal video‐assisted thoracoscopic surgery (UVATS), especially in more complex procedures such as segmentectomy. We therefore aimed to investigate the worthiness of unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdellateef, Amr, Ma, Xiaoyu, Chen, Zhigang, Wu, Liang, Cai, Jianqiao, Jiang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262898/
https://www.ncbi.nlm.nih.gov/pubmed/32222039
http://dx.doi.org/10.1111/1759-7714.13392
_version_ 1783540710288392192
author Abdellateef, Amr
Ma, Xiaoyu
Chen, Zhigang
Wu, Liang
Cai, Jianqiao
Jiang, Lei
author_facet Abdellateef, Amr
Ma, Xiaoyu
Chen, Zhigang
Wu, Liang
Cai, Jianqiao
Jiang, Lei
author_sort Abdellateef, Amr
collection PubMed
description BACKGROUND: Subxiphoid uniportal video‐assisted thoracoscopic surgery (SVATS) is more technically challenging than intercostal uniportal video‐assisted thoracoscopic surgery (UVATS), especially in more complex procedures such as segmentectomy. We therefore aimed to investigate the worthiness of undertaking the more demanding subxiphoid approach in patients who had undergone anatomical segmentectomy for stage IA non‐small cell lung cancer (NSCLC). METHODS: A total of 491 patients were included in our study who had undergone anatomical segmentectomy for stage IA non‐small cell lung cancer from September 2014 to April 2018. They were divided into two groups; 278 patients in the UVATS group and 213 patients in the SVATS group. Different perioperative variables, postoperative pain, quality of life and cost were analyzed and compared between both groups. RESULTS: The SVATS group showed a significantly longer operative time (P = 0.007) and more operative blood loss than the intercostal group (P = 0.004). There was no significant difference between both groups regarding postoperative drainage, duration of chest tube, postoperative hospital stay, operative conversion or postoperative complications. The SVATS group showed a significantly lower pain score postoperatively (P < 0.001). In addition, the SVATS group showed a significantly better postoperative quality of life score along the first postoperative year (P < 0.001). UVATS segmentectomy appeared to be significantly cheaper than SVATS segmentectomy (P < 0.001). CONCLUSIONS: SVATS segmentectomy for stage IA lung cancer is a safe procedure that is worth proceeding with as it is associated with better postoperative pain and better quality of life in the first postoperative year. Further studies are recommended to evaluate the actual cost‐effectiveness of SVATS segmentectomy. KEY POINTS: • Significant findings of the study Subxiphoid uniportal approach for pulmonary segmentectomy is safe and feasible approach. It has better postoperative pain and better quality of life than the uniportal intercostal approach; however, it is more expensive. • What this study adds Subxiphoid uniportal approach for pulmonary segmentectomy gives a better quality of life in Chinese patients than the intercostal approach; however, it is more expensive.
format Online
Article
Text
id pubmed-7262898
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-72628982020-06-03 Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness Abdellateef, Amr Ma, Xiaoyu Chen, Zhigang Wu, Liang Cai, Jianqiao Jiang, Lei Thorac Cancer Original Articles BACKGROUND: Subxiphoid uniportal video‐assisted thoracoscopic surgery (SVATS) is more technically challenging than intercostal uniportal video‐assisted thoracoscopic surgery (UVATS), especially in more complex procedures such as segmentectomy. We therefore aimed to investigate the worthiness of undertaking the more demanding subxiphoid approach in patients who had undergone anatomical segmentectomy for stage IA non‐small cell lung cancer (NSCLC). METHODS: A total of 491 patients were included in our study who had undergone anatomical segmentectomy for stage IA non‐small cell lung cancer from September 2014 to April 2018. They were divided into two groups; 278 patients in the UVATS group and 213 patients in the SVATS group. Different perioperative variables, postoperative pain, quality of life and cost were analyzed and compared between both groups. RESULTS: The SVATS group showed a significantly longer operative time (P = 0.007) and more operative blood loss than the intercostal group (P = 0.004). There was no significant difference between both groups regarding postoperative drainage, duration of chest tube, postoperative hospital stay, operative conversion or postoperative complications. The SVATS group showed a significantly lower pain score postoperatively (P < 0.001). In addition, the SVATS group showed a significantly better postoperative quality of life score along the first postoperative year (P < 0.001). UVATS segmentectomy appeared to be significantly cheaper than SVATS segmentectomy (P < 0.001). CONCLUSIONS: SVATS segmentectomy for stage IA lung cancer is a safe procedure that is worth proceeding with as it is associated with better postoperative pain and better quality of life in the first postoperative year. Further studies are recommended to evaluate the actual cost‐effectiveness of SVATS segmentectomy. KEY POINTS: • Significant findings of the study Subxiphoid uniportal approach for pulmonary segmentectomy is safe and feasible approach. It has better postoperative pain and better quality of life than the uniportal intercostal approach; however, it is more expensive. • What this study adds Subxiphoid uniportal approach for pulmonary segmentectomy gives a better quality of life in Chinese patients than the intercostal approach; however, it is more expensive. John Wiley & Sons Australia, Ltd 2020-03-28 2020-06 /pmc/articles/PMC7262898/ /pubmed/32222039 http://dx.doi.org/10.1111/1759-7714.13392 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Abdellateef, Amr
Ma, Xiaoyu
Chen, Zhigang
Wu, Liang
Cai, Jianqiao
Jiang, Lei
Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness
title Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness
title_full Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness
title_fullStr Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness
title_full_unstemmed Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness
title_short Subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage I non‐small cell lung cancer: Feasibility, quality of life and financial worthiness
title_sort subxiphoid uniportal thoracoscopic pulmonary segmentectomy for stage i non‐small cell lung cancer: feasibility, quality of life and financial worthiness
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262898/
https://www.ncbi.nlm.nih.gov/pubmed/32222039
http://dx.doi.org/10.1111/1759-7714.13392
work_keys_str_mv AT abdellateefamr subxiphoiduniportalthoracoscopicpulmonarysegmentectomyforstageinonsmallcelllungcancerfeasibilityqualityoflifeandfinancialworthiness
AT maxiaoyu subxiphoiduniportalthoracoscopicpulmonarysegmentectomyforstageinonsmallcelllungcancerfeasibilityqualityoflifeandfinancialworthiness
AT chenzhigang subxiphoiduniportalthoracoscopicpulmonarysegmentectomyforstageinonsmallcelllungcancerfeasibilityqualityoflifeandfinancialworthiness
AT wuliang subxiphoiduniportalthoracoscopicpulmonarysegmentectomyforstageinonsmallcelllungcancerfeasibilityqualityoflifeandfinancialworthiness
AT caijianqiao subxiphoiduniportalthoracoscopicpulmonarysegmentectomyforstageinonsmallcelllungcancerfeasibilityqualityoflifeandfinancialworthiness
AT jianglei subxiphoiduniportalthoracoscopicpulmonarysegmentectomyforstageinonsmallcelllungcancerfeasibilityqualityoflifeandfinancialworthiness